These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26848770)

  • 1. Genetic evaluation of BRCA1 associated a complex genes with triple-negative breast cancer susceptibility in Chinese women.
    Ling H; Li S; Wu Y; Zheng YZ; Qiao F; Yao L; Cao ZG; Ye FG; Wu J; Hu X; Wang B; Shao ZM
    Oncotarget; 2016 Mar; 7(9):9759-72. PubMed ID: 26848770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NBA1/MERIT40 and BRE interaction is required for the integrity of two distinct deubiquitinating enzyme BRCC36-containing complexes.
    Hu X; Kim JA; Castillo A; Huang M; Liu J; Wang B
    J Biol Chem; 2011 Apr; 286(13):11734-45. PubMed ID: 21282113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MERIT40 facilitates BRCA1 localization and DNA damage repair.
    Feng L; Huang J; Chen J
    Genes Dev; 2009 Mar; 23(6):719-28. PubMed ID: 19261748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NBA1, a new player in the Brca1 A complex, is required for DNA damage resistance and checkpoint control.
    Wang B; Hurov K; Hofmann K; Elledge SJ
    Genes Dev; 2009 Mar; 23(6):729-39. PubMed ID: 19261749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vivo dynamic organization of BRCA1-A complex proteins at DNA damage-induced nuclear foci.
    Mok MT; Henderson BR
    Traffic; 2012 Jun; 13(6):800-14. PubMed ID: 22420687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation screening of the MERIT40 gene encoding a novel BRCA1 and RAP80 interacting protein in breast cancer families.
    Solyom S; Patterson-Fortin J; Pylkäs K; Greenberg RA; Winqvist R
    Breast Cancer Res Treat; 2010 Feb; 120(1):165-8. PubMed ID: 19572197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline and tumor BRCA1/2 pathogenic variants in Chinese triple-negative breast carcinomas.
    Ji G; Bao L; Yao Q; Zhang J; Zhu X; Bai Q; Shao Z; Yang W; Zhou X
    J Cancer Res Clin Oncol; 2021 Oct; 147(10):2935-2944. PubMed ID: 34254208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline mutations in DNA repair genes may predict neoadjuvant therapy response in triple negative breast patients.
    Spugnesi L; Gabriele M; Scarpitta R; Tancredi M; Maresca L; Gambino G; Collavoli A; Aretini P; Bertolini I; Salvadori B; Landucci E; Fontana A; Rossetti E; Roncella M; Naccarato GA; Caligo MA
    Genes Chromosomes Cancer; 2016 Dec; 55(12):915-924. PubMed ID: 27328445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast Cancer and High-grade Serous Ovarian Cancer.
    Lønning PE; Nikolaienko O; Pan K; Kurian AW; Eikesdal HP; Pettinger M; Anderson GL; Prentice RL; Chlebowski RT; Knappskog S
    JAMA Oncol; 2022 Nov; 8(11):1579-1587. PubMed ID: 36074460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MERIT40 controls BRCA1-Rap80 complex integrity and recruitment to DNA double-strand breaks.
    Shao G; Patterson-Fortin J; Messick TE; Feng D; Shanbhag N; Wang Y; Greenberg RA
    Genes Dev; 2009 Mar; 23(6):740-54. PubMed ID: 19261746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubc13/Rnf8 ubiquitin ligases control foci formation of the Rap80/Abraxas/Brca1/Brcc36 complex in response to DNA damage.
    Wang B; Elledge SJ
    Proc Natl Acad Sci U S A; 2007 Dec; 104(52):20759-63. PubMed ID: 18077395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients.
    Rashid MU; Muhammad N; Bajwa S; Faisal S; Tahseen M; Bermejo JL; Amin A; Loya A; Hamann U
    BMC Cancer; 2016 Aug; 16(1):673. PubMed ID: 27553291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple-negative breast cancer and PTEN (phosphatase and tensin homologue) loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer.
    Phuah SY; Looi LM; Hassan N; Rhodes A; Dean S; Taib NA; Yip CH; Teo SH
    Breast Cancer Res; 2012 Nov; 14(6):R142. PubMed ID: 23116406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The possible role of EZH2 and DNMT1 polymorphisms in sporadic triple-negative breast carcinoma in southern Chinese females.
    Tao R; Chen Z; Wu P; Liu C; Peng Y; Zhao W; Hu C; Feng J
    Tumour Biol; 2015 Dec; 36(12):9849-55. PubMed ID: 26162541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of recurrent BRCA1 mutation and its clinical relevance in Chinese Triple-negative breast cancer cohort.
    Liu X; Li H; Shao B; Wu J; Kong W; Song G; Jiang H; Wang J; Wan F
    Cancer Med; 2017 Mar; 6(3):547-554. PubMed ID: 28135048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the genes coding for the BRCA1-interacting proteins, RAP80 and Abraxas (CCDC98), in high-risk, non-BRCA1/2, multiethnic breast cancer cases.
    Novak DJ; Sabbaghian N; Maillet P; Chappuis PO; Foulkes WD; Tischkowitz M
    Breast Cancer Res Treat; 2009 Sep; 117(2):453-9. PubMed ID: 18695986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low prevalence of germline PALB2 mutations in Australian triple-negative breast cancer.
    Wong-Brown MW; Avery-Kiejda KA; Bowden NA; Scott RJ
    Int J Cancer; 2014 Jan; 134(2):301-5. PubMed ID: 23824750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline RAP80 mutations and susceptibility to breast cancer.
    Akbari MR; Ghadirian P; Robidoux A; Foumani M; Sun Y; Royer R; Zandvakili I; Lynch H; Narod SA
    Breast Cancer Res Treat; 2009 Jan; 113(2):377-81. PubMed ID: 18306035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria.
    Hoyer J; Vasileiou G; Uebe S; Wunderle M; Kraus C; Fasching PA; Thiel CT; Hartmann A; Beckmann MW; Lux MP; Reis A
    BMC Cancer; 2018 Sep; 18(1):926. PubMed ID: 30257646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of BRCA1 5382insC mutation in triple negative breast cancer in Tunisia.
    Mahfoudh W; Bettaieb I; Ghedira R; Snoussi K; Bouzid N; Klayech Z; Gabbouj S; Remadi Y; Hassen E; Bouaouina N; Zakhama A
    J Transl Med; 2019 Apr; 17(1):123. PubMed ID: 30975216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.